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Background-—Heart rate (HR) recovery has been investigated in specific patient cohorts, but there is less information about the
role of HR recovery in general populations. We investigated whether HR recovery has long-term prognostic significance in primary
prevention.
Methods and Results-—Exercise tests performed between 1993 and 2010 on patients aged 30 to 79 years without cardiovascular
disease were included. Mortality was determined from Mayo Clinic records and Minnesota Death Index. Total, cardiovascular, and
non-cardiovascular mortality was reported according to HR recovery <13 bpm using Cox regression. 19 551 patients were
included, 6756 women (35%), age 5110 years. There were 1271 deaths over follow-up of 125 years. HR recovery declined
after age 60, and was also lower according to diabetes mellitus, hypertension, obesity, current smoking, and poor cardiorespiratory
fitness but not sex or b-blockers. Adjusting for these factors, abnormal HR recovery was a significant predictor of total (hazard ratio
[95% confidence interval]=1.56 [1.384–1.77]), cardiovascular (1.95 [1.57–2.42]), and non-cardiovascular death (1.41 [1.22–1.64]).
Hazard ratios for cardiovascular death according to abnormal HR recovery were significant in all age groups (30–59, 60–69, 70–
79), in both sexes, in patients with and without hypertension, obesity, and diabetes mellitus, but not in patients taking b-blockers,
current smokers, and patients with normal cardiorespiratory fitness.
Conclusions-—HR recovery is a powerful prognostic factor predicting total, cardiovascular, and non-cardiovascular death in a
primary prevention cohort. It performs consistently well according to sex, age, obesity, hypertension, and diabetes mellitus but
shows diminished utility in patients taking b-blockers, current smokers, and patients with normal cardiorespiratory fitness. ( J Am
Heart Assoc. 2018;7:e008143. DOI: 10.1161/JAHA.117.008143.)
Key Words: exercise testing • heart rate recovery • mortality • primary prevention
I t is important for both good patient care and healthcareeconomics to gain the most information possible from
each test performed. This is true for the exercise test, which
provides both diagnostic and prognostic information.1 This
means not only looking at the ST-segment response but also
accurately reporting and identifying the significance of
functional aerobic capacity (FAC) and exercise heart rate
(HR) responses, including the HR recovery.
Ever since the concept of HR recovery on the exercise test
was proposed by Cole and colleagues in 1999,2 investigations
have consistently demonstrated its ability to identify higher-risk
patients in mixed cohorts (with and without documented
coronary artery disease),3 in patients referred for nuclear stress
testing and possible coronary angiography,4 and patients with
symptomatic coronary artery disease.5 HR recovery is impaired
in patients with obstructive sleep apnea,6 silent myocardial
ischemia,7 heart failure with preserved ejection fraction,8 and
type 2 diabetes mellitus,9 although these studies did not report
long-term outcomes. We have also recently published data
showing that HR recovery is one of several exercise HR
responses that are impaired in patients with diabetes mellitus
and that it contributes significantly to the increased all-cause
mortality versus patients without diabetes mellitus.10 The
prognostic performance of HR recovery in a primary prevention
population without documented coronary artery disease has
not been fully examined. In a primary prevention cohort,
cardiovascular deaths may not constitute the majority of all
From the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN
(N.S., K.A.G.C., N.H., S.F., J.G.M., F.L.-J., T.G.A.); Heart and Vascular Center,
Semmelweis University, Budapest, Hungary (N.S., B.M.); Csolnoky Ferenc
Hospital, Veszprem, Hungary (T.S.).
*Dr Tibor Sydo and Dr Nora Sydo contributed equally to this work.
The abstract of this work was presented at the American Heart Association
Scientific Sessions, November 11 to 15, 2017, in Anaheim, CA.
Correspondence to: Thomas G. Allison, PhD, MPH, FACC, Department of
Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN
55905. E-mail: allison.thomas@mayo.edu
Received November 27, 2017; accepted February 13, 2018.
ª 2018 The Authors. Published on behalf of the American Heart Association,
Inc., by Wiley. This is an open access article under the terms of the Creative
Commons Attribution-NonCommercial License, which permits use, distribu-
tion and reproduction in any medium, provided the original work is properly
cited and is not used for commercial purposes.
DOI: 10.1161/JAHA.117.008143 Journal of the American Heart Association 1
ORIGINAL RESEARCH
 by guest on M
ay 5, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
deaths, so it is important to know if noncardiovascular deaths
are also related to HR recovery.
Another issue is whether adjusting the HR recovery for
different subgroups will improve its performance. Among
exercise test prognostic factors, FAC is adjusted for age and
sex, whereas peak exercise HR is adjusted for age and b-
blocker use: either ignored in b-blocked patients or given a
different age-adjusted target.11 It is therefore essential to
determine if HR recovery varies by age, sex, and b-blocker use
and whether adjustment for any of these factors improves its
performance.12 These questions represent the focus of the
current investigation while also validating the prognostic value
of HR recovery in a primary prevention cohort.
Methods
Due to patient confidentiality issues, the data, analyticmethods,
and study materials will not be made available online to other
researchers for purposes of reproducing the results or replicat-
ing the procedure. However, the corresponding author may be
able to provide some materials upon request. This was a
retrospective study approved by the Mayo Clinic Rochester
InstitutionalReviewBoard.Subjectsnotconsenting tohave their
data used in researchunderMinnesotaStatute (§144.335)were
excluded.13 The Mayo Integrated Stress Center database was
queried for the period September 21, 1993, through December
20, 2010.
Study Population
Inclusion criteria were as follows: nonimaging stress test,
Minnesota resident, symptom-limited treadmill test performed
on theBruceprotocol, aged30 to79 years. Testswere excluded
if (1) the patient had a documented history of cardiovascular
disease, including ischemicheart diseases, heart failure, cardiac
surgery, structuralorvalvularheartdiseases,majorarrhythmias,
defibrillator or pacemaker, congenital heart diseases, cere-
brovascular diseases, and peripheral vascular diseases; (2) the
test was not symptom limited but stopped because of ST
changes, major arrhythmias, or abnormal blood pressure
response; (3) active recovery for at least 1 minute was not
completed; or (4) peak exercise or 1-minute recovery HR were
impaired by a paroxysmal arrhythmia. Where multiple qualifying
tests were available for a given patient, the first test chronolog-
ically was chosen to maximize follow-up.
Clinical Data
Demographic and clinical information were collected prospec-
tively at the time of the stress study. HR and other exercise
data were uploaded into the database electronically from the
GE CASE stress testing systems (Milwaukee, WI). Patient
characteristics including age, sex, anthropometrics, and
comorbidities were extracted from patient medical charts
and patient interview at the time of the exercise test. We
specifically looked for diabetes mellitus, hypertension, obesity
(defined as body mass index ≥30 kg/m2), current smoking,
and use of an HR-lowering drug (b-blocker or nondihydropy-
ridine calcium channel blocker).
Exercise Test Protocol and Variables
Symptom-limited treadmill exercise testing was performed
on usual medications using the standard Bruce protocol
according to American College of Cardiology/American
Heart Association guidelines.14,15 Resting HR and blood
pressure measurements were obtained in the standing
position. Symptoms, blood pressure, HR, rating of perceived
exertion, and workload were electronically entered into the
database during the final minute of each stage of exercise,
peak exercise, 1 and 3 minutes of active recovery at 1.7
MPH/0% grade, and 6 minutes post peak exercise in seated
recovery.
Exercise test interpretation data including reason for
termination, symptoms, abnormal signs, and exercise elec-
trocardiographic analysis were added to the database imme-
diately after the test. FAC was expressed as 100%9actual
performance time/predicted performance time based on
previous publications from our laboratory.16 Peak HR was
also expressed as percent predicted peak HR.17 HR recovery
Clinical Perspective
What Is New?
• We give a detailed description about the role and prognostic
performance of HR recovery in a large primary prevention
population.
• We show that heart rate (HR) recovery is associated with a
number of cardiovascular risk factors including diabetes
mellitus, hypertension, current smoking and poor cardiores-
piratory fitness but is not affected by sex or use of HR-
lowering drug.
What Are the Clinical Implications?
• Theexercise test isan importantprognostic toolwith theability
to predict mortality.
• Using nonelectrocardiographic parameters such as HR
recovery, we can predict not only total mortality but show
that abnormal HR recovery is an even stronger predictor of
cardiovascular death and predicts also non-cardiovascular
death.
• While HR recovery performs equally well in all age groups and in
both men and women, it is less useful in patients with normal
cardiorespiratory fitness or in those taking a b-blocker.
DOI: 10.1161/JAHA.117.008143 Journal of the American Heart Association 2
Prognostic Performance of Heart Rate Recovery Sydo et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on M
ay 5, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
was calculated as peak exercise HR minus HR at 1 minute of
active recovery at 1.7 MPH/0% grade. An abnormal exercise
ECG was defined as any ST depression or elevation >1.0 mm
irrespective of the resting ECG, while an abnormal exercise
ECG was considered positive only if the resting ECG did not
present with significant ST-T abnormalities, the patient was
not taking digitalis, and rate-related left bundle branch block
did not occur.
Mortality Outcomes
Outcomes were taken from Mayo Clinic patient records and
the Minnesota Death Index, which was reviewed in March
2016. A death was considered to be cardiovascular-related if
a cardiovascular condition was included among the first 3
listed causes in the Minnesota Death Index; otherwise, the
death was considered non-cardiovascular. Mortality data were
classified using the International Classification of Diseases,
Ninth Revision (ICD-9; 391, 391.9, 394–398, 402, 404, 410–
414, 415–417, 420–429, 430–438, 440–448, 451–454,
456–459) and ICD-9 (I101, I05–I09, I11, I13, I20–I25, I26–
I28, I30–I52, I60–69, I70–I79, I80–89) codes.
Statistical Analysis
Patient characteristics, outcomes, and exercise data were
analyzed by decade of age. Differences among continuous
variables by age group were assessed by analysis of variance
under the general linear model with multiple comparisons
handled by Tukey’s method, while Pearson’s chi-squared test
of continuity was used to test age group differences in
discrete variables. Similar to a previous paper on peak HR by
age and sex from our laboratory,17 the first step in the
analysis was to determine factors that significantly affect HR
recovery using stepwise multivariate regression, then to
create a “pure cohort” by eliminating patients with those
factors. This allowed us to identify the true physiologic change
in HR recovery with age and sex.
The next step in the analysis was to determine if the
standard definition of abnormal HR recovery of <13 bpm
would predict the outcomes of total death, cardiovascular
death, and non-cardiovascular death in this primary preven-
tion data set using the whole cohort. Cox proportional hazards
regression was employed for this analysis. Further analyses
were stratified by age, sex, FAC, presence of hypertension,
diabetes mellitus, current smoking, and use of an HR-lowering
drug. Differences in hazard ratios between different strata
were determined by the Z-score method. Statistics were
performed using SAS 9.4 (Raleigh, NC). P<0.05 was consid-
ered significant for all analyses.
Results
Study Population
A total of 19 551 patients were available for analysis. Their
demographic and clinical data, stratified by decade of age, are
provided in Table 1, along with the long-term outcome data,
shown here in Table 1 for convenience. Diabetes mellitus and
hypertension rates increased progressively with age, while
obesity and current smoking showed an opposite trend. Not
surprisingly, there were relatively more women in the older
Table 1. Baseline Characteristics and Outcomes in the 5 Age Groups for the Full Clinical Cohort
Age: 30 to
39 (N=2664)
Age: 40 to
49 (N=6703)
Age: 50 to
59 (N=6047)
Age: 60 to
69 (N=3112)
Age 70 to
79 (N=1025) P Value
Age, y 35.72.81 44.72.82 54.02.93 63.92.84 73.02.65 <0.0001
Female 810 (30.4)1 2170 (32.4)1 2097 (34.7)2 2171 (40.8)3 408 (39.8)3 <0.0001
BMI, kg/m2 29.26.33 28.85.12 28.85.12 28.44.72 27.24.01 <0.0001
Hypertension 285 (10.7)1 1000 (14.9)2 1492 (24.7)3 1059 (34.0)4 444 (43.3)5 <0.0001
Diabetes mellitus 83 (3.1)1 273 (4.1)1 382 (6.3)2 248 (8.0)3 95 (9.3)3 <0.0001
Current smoker 416 (16.2)4 892 (13.7)3 633 (10.8)2 196 (6.6)1 53 (5.3)1 <0.0001
Obesity 1046 (39.3)4 2410 (36.0)2,3 2259 (37.4)3,4 1072 (34.4)2 255 (24.9)1 <0.0001
Poor CRF 866 (32.5)4 1532 (21.4)1,2 1245 (20.6)1 724 (23.3)2,3 278 (27.1)3 <0.0001
Deaths 40 (1.5)1 158 (2.4)1 287 (4.8)2 437 (14.0)3 350 (34.2)4 <0.0001
Cardiovascular death 11 (0.4)1 50 (0.8)1 69 (1.1)1 133 (4.3)2 142 (13.8)3 <0.0001
Non-cardiovascular death 29 (1.1)1 108 (1.6)1 218 (3.6)2 304 (9.8)3 208 (20.3)4 <0.0001
Continuous data are presented as meanSD; categorical data as N (percentage of sample). Poor cardiorespiratory fitness (CRF) defined as functional aerobic capacity (FAC) <80%
predicted for age and sex on exercise test. Different superscripts indicate a statistically significant difference between age groups. Superscript 1 is arbitrarily set at the lowest value for
each variable. BMI indicates body mass index.
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age groups. Poor cardiorespiratory fitness (CRF)—identified
by an FAC <80%—was highest in the youngest age group,
likely reflecting referral bias in younger patients.
Exercise Test Results
Table 2 provides the exercise test data for the full clinical
cohort of 19 551 patients. Because of the large sample size,
even minor differences, such as in resting HR or highest rating
of perceived exertion, reached statistical significance,
although some age trends were pronounced, such as the
well-documented trend toward decreasing peak exercise HR
with age.17 HR recovery also declined significantly with age,
while the proportion of patients with HR recovery <13 bpm
increased significantly. Not surprisingly, the number of
patients taking HR-lowering drugs increased significantly with
age. The frequency of both positive and all abnormal exercise
ECGs also increased steadily with age.
Factors Affecting Heart Rate Recovery
For the next step in the analysis, stepwise multivariate
regression to determine factors significantly affecting HR
recovery was performed. The results are shown in Table 3.
The N for Table 3 was 18 887, as 664 patients (3.4%) had 1
missing covariate, principally smoking status. Intercept and
age were highly significant in the regression, and 5 other
factors—poor CRF, obesity, current smoking, hypertension,
and diabetes mellitus—all showed significant (negative)
effects on HR recovery, whereas sex, taking an HR-lowering
drug, and an abnormal exercise ECG did not affect HR
recovery significantly. Only age and poor CRF contributed
more than 1% to the model R2. Based on these results, we
formed our pure cohort by eliminating patients with the 6 HR
recovery-lowering factors, leaving us 7852 patients.
HR Recovery in Age Groups
Table 4 shows means, medians, and interquartile range for HR
recovery and percentage of patients with HR recovery less
than the traditional cut point of 13 bpm in the first minute of
active recovery according to decade of age in the pure cohort.
We propose that these data represent the true effect of age
on HR recovery. At each age group, HR recovery in the pure
cohort was higher than in the full cohort, as expected.
Average HR recovery is relatively constant from ages 30 to 39
through ages 50 to 59, then begins to decrease more rapidly
as age increases. The percentage of patients with an HR
recovery below the traditional cut point of 13 bpm is only
8.4% at age 30 to 39 but rises to 41.5% by age 70 to 79.
Table 2. Exercise Test Results for the Full Clinical Cohort
Age: 30 to 39
(N=2664)
Age: 40 to 49
(N=6703)
Age: 50 to 59
(N=6047)
Age: 60 to 69
(N=3112)
Age 70 to 79
(N=1025) P Value
FAC, % 88.419.31 94.920.22 97.121.13 96.923.53 93.824.72 <0.0001
Resting HR, bpm 78.713.25 77.112.84 76.412.73 75.512.92 74.012.41 <0.0001
Peak exercise HR, bpm 176.615.35 170.815.74 162.916.03 152.717.32 142.717.31 <0.0001
Percent pred. peak HR 96.38.31 97.68.82,3 98.09.53 97.110.92 95.911.51 <0.0001
HR-lowering drug use 142 (5.3)1 436 (6.5)1 563 (9.3)2 424 (13.6)3 196 (19.2)4 <0.0001
Peak HR <85% pred. 241 (9.1)1 568 (8.5)1 583 (9.6)1 415 (13.3)2 169 (16.5)3 <0.0001
HR recovery 21.28.15 20.58.04 18.97.93 16.07.52 12.97.41 <0.0001
HR recovery <13 bpm 340 (12.8)1 993 (14.8)1 1279 (21.2)2 1022 (32.8)3 512 (50.0)4 <0.0001
Resting SBP, mm Hg 118.814.91 120.015.62 124.017.33 129.518.74 133.220.35 <0.0001
Resting DBP, mm Hg 79.711.02 79.711.12 80.510.83 79.910.92,3 77.911.31 <0.0001
Peak SBP, mm Hg 171.023.61 174.123.62 179.424.63 182.325.24 177.420.23 <0.0001
Peak DBP, mm Hg 72.916.81 74.915.82 77.415.53 78.715.14 77.214.83,4 <0.0001
Highest RPE 18.30.84 18.30.83,4 18.20.83 18.00.92 17.91.01 <0.0001
Positive exercise ECG 17 (0.6)1 150 (2.2)2 266 (4.4)3 217 (7.0)4 95 (9.3)5 <0.0001
Abnormal exercise ECG 62 (2.3)1 300 (4.5)2 474 (7.8)3 356 (11.4)4 146 (14.2)5 <0.0001
Continuous data are presented as meanSD; categorical data as number (percentage of sample). Functional aerobic capacity (FAC) defined as 100%9actual time/predicted time on Bruce
protocol for age and sex. Rating of perceived exertion measured on standard Borg Scale (6–20). Positive exercise ECG defined by standard methods. Abnormal exercise ECG defined as
positive or abnormal but not diagnostic due to resting ST-T abnormalities. Different superscripts indicate a statistically significant difference between age groups. Superscript 1 is arbitrarily
set at the lowest value for each variable. DBP indicates diastolic blood pressure; HR, heart rate; RPE, rating of perceived exertion; and SBP, systolic blood pressure.
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Outcomes
Therewere a total of 1271deaths (6.5%) in the full cohort over an
average follow-upof12.45.0 years. Consistentwith exclusion
of baseline cardiovascular disease and residence in a state
(Minnesota) with overall low cardiovascular death rates, there
were actually more non-cardiovascular deaths (867, 4.4%) than
cardiovascular deaths (405, 2.1%). Not surprisingly, women
were at a lower age-adjusted risk of death (0.70 with 95%
confidence interval [0.62–0.90]), compared with men.
Using the full clinical cohort, an abnormal HR recovery by
the traditional value of <13 bpm in the first minute post peak
exercise during active recovery was a significant risk factor for
death from any cause, cardiovascular death, and even non-
cardiovascular death in this primary prevention cohort. Hazard
ratios for an abnormal HR recovery predicting death,
cardiovascular death, and also non-cardiovascular death are
shown in Figure 1. Three models are shown for each
outcome: unadjusted; adjusted for age and sex; and fully
adjusted for age, sex, diabetes mellitus, hypertension, obesity,
current smoking, and poor CRF. The hazard ratios in all
models for all outcomes are statistically significant. The
hazard ratio for abnormal HR recovery for cardiovascular
versus non-cardiovascular death was significantly higher in
the unadjusted (P<0.0001), age-sex–adjusted models
(P<0.001), and fully adjusted (P<0.02) models. We have
therefore demonstrated that an abnormal HR recovery is a
significant predictor of death, cardiovascular death, and even
non-cardiovascular death in our primary prevention cohort.
For further analyses, we focused on cardiovascular mor-
tality because its association with abnormal HR recovery was
strongest.
We divided the full cohort according to 3 age groups, 30 to
59 (based on the minimal change in HR recovery across this
age range, as mentioned above), then 60 to 69, and 70 to 79,
as HR recovery declined significantly over these older age
groups. Hazard ratios for cardiovascular death according to
HR recovery in the 3 age groups are shown in Figure 2.
Hazard ratios were statistically significant in all age groups
and not significantly different among the 3 age groups.
Figure 2 also shows the predictive value of abnormal HR
recovery according to sex, 3 levels of CRF, smoking status,
Table 3. Multivariate Regression Analysis to Determine Factors Affecting HR Recovery
Variable
Parameter
estimate
Standard
error Partial R2 Model R2 F P Value
Intercept 31.79 0.29 12 107.3 <0.0001
Age 0.21 0.0055 0.071 0.071 1445.6 <0.0001
Poor CRF 3.92 0.14 0.063 0.134 1368.1 <0.0001
Obesity 1.32 0.12 0.0060 0.140 132.5 <0.0001
Current smoking 1.90 0.18 0.0051 0.145 113.2 <0.0001
Hypertension 1.08 0.15 0.0027 0.148 60.9 <0.0001
Diabetes mellitus 1.46 0.25 0.0016 0.149 35.8 <0.0001
CRF indicates cardiorespiratory fitness; HR, heart rate.
Table 4. Heart Rate Recovery Distribution in the Pure Cohort
Age: 30 to 39
(N=1056)
Age: 40 to 49
(N=2967)
Age: 50 to 59
(N=2390)
Age: 60 to 69
(N=1116)
Age 70 to 79
(N=323) P Value
Resting HR, bpm 76.112.72 74.812.41 74.612.11 75.112.11,2 73.811.11 <0.001
Peak exercise HR, bpm 182.411.45 176.411.94 168.612.93 159.113.72 149.414.61 <0.001
Female (%) 327 (31.0)1 990 (33.4)1,2 880 (36.8)2 509 (45.6)3 147 (45.5)3 <0.001
HR-lowering drug use (%) 23 (2.2)1,2 54 (1.8)1 60 (2.5)1,2 43 (3.8)2 23 (7.1)3 <0.001
Mean HR recovery, bpm 22.98.34 22.38.24 21.18.03 18.47.42 14.97.31 <0.001
Median HR recovery, bpm 22 22 21 18 14
Interquartile range, bpm 17–28 17–27 16–26 13–23 10–20
HR recovery <13 bpm 87 (8.4)1 298 (10.0)1 311 (13.0)2 240 (21.5)3 134 (41.5)4 <0.001
Continuous data are presented as meanSD; categorical data as number (percentage of sample). Pure cohort created by excluding patients with hypertension, diabetes mellitus, current
smoking, obesity (BMI ≥30 kg/m2), and poor cardiorespiratory fitness (functional aerobic capacity <80% age-sex predicted). Different superscripts indicate a statistically significant
difference between groups. Superscript 1 is arbitrarily set at the lowest value for each variable. HR indicates heart rate.
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diabetes mellitus, hypertension, obesity, and use of an HR-
lowering drug. Abnormal HR recovery significantly predicted
outcomes in all subgroups except current smokers, patients
with normal CRF (≥100% FAC), and patients taking an HR-
lowering drug; in these subgroups, the confidence intervals in
the hazard ratios included 1.0. As noted in the displayed P
values, there was a significant difference in the hazard ratios
in poor versus normal CRF, whereas the differences in hazard
ratios according to HR-lowering drug and current smoking
were of borderline significance. On the other hand, abnormal
HR recovery did not perform differently in males versus
females; in reduced versus normal CRF; among the 3 age
groups; or in patients with or without diabetes mellitus,
hypertension, or obesity,
Discussion
This retrospective study confirmed the hypothesis that HR
recovery has prognostic significance in a primary prevention
cohort of almost 20 000 patients without a documented
history of known cardiovascular disease. We show that HR
recovery is a significant predictor of not only of total and
cardiovascular death but non-cardiovascular death as well. HR
recovery is impaired by a number of cardiovascular risk factors
including diabetes mellitus, hypertension, obesity, smoking,
and poor CRF. HR recovery decreases significantly with age,
especially above 50 years, but it performs equally well in all
adult age groups. We also show that HR recovery predicts
cardiovascular death equally in men versus women and
patients with and without hypertension, diabetes mellitus, or
obesity, but its prognostic performance is limited in patients
with normal CRF, current smokers, and those taking HR-
lowering drugs.
The first comprehensive study of HR recovery was from
Cole et al in 1999 and included patients who were referred
for a first symptom-limited exercise test and single-photon-
emission computed tomography with thallium scintigraphy.
These patients were candidates for initial angiography.2 Lauer
postulated that HR recovery is a reflection of decreased vagal
activity and established the formula calculating HR recovery
as peak HR (HR at 1 minute in the active recovery) and
defined it as abnormal if <13 bpm. Extended analyses on
9454 patients undergoing myocardial perfusion imaging
confirmed that HR recovery is a powerful predictor of overall
mortality independent of workload, presence of myocardial
perfusion defects, and Duke treadmill score.3 Other studies
have investigated the predictive value of HR recovery in
various high-risk populations such as heart failure, diabetes
mellitus, and coronary artery disease.5,18–21 They all con-
firmed that HR recovery is an independent predictor of both
Figure 1. Hazard ratios with 95% confidence intervals for an abnormal heart rate recovery predicting
death, cardiovascular death, and non-cardiovascular death. Three models are shown for each outcome:
unadjusted; adjusted for age and sex; fully adjusted for age, sex, diabetes mellitus, hypertension, obesity,
current smoking, and poor cardiorespiratory fitness. Hazard ratios for cardiovascular and non-
cardiovascular death are compared by the Z-score method.
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cardiovascular and total mortality in their specific patient
populations. In an American Heart Association statement
published in 2005 in Circulation, exercise testing was
identified as an important tool of assessing and refining
prognosis, particularly when emphasis is placed on non-ECG
measures including HR recovery.22
Data on HR recovery in lower-risk cohorts are more limited.
The prognostic importance (all-cause mortality and nonfatal
myocardial infarction) of HR recovery has been confirmed in
patients with chest pain with low Duke treadmill scores.23 Our
group also previously identified the prognostic role of HR
recovery in 2014 in a smaller population with 6546 patients,
focusing on the association of HR recovery with exercise test
parameters and all-cause mortality.24 The ability of HR
recovery to predict non-cardiovascular mortality has not been
previously addressed.
Two prior studies investigated the effect of sex on HR
recovery and mortality.25,26 Both suggested that abnormal HR
recovery was independent of sex and had similar prognostic
value in both men and women, as our study confirmed.
Two prior studies reported HR recovery in older
patients,27,28 but they did not compare the impact of age
on its prognostic value, as we have done here.
Although obesity, hypertension, and diabetes mellitus are
all affected the HR recovery, abnormal HR recovery had
similar prognostic significance in patients with or without
obesity, hypertension, and diabetes mellitus. Smokers also
had lower HR recovery, but abnormal HR recovery was not a
significant predictor of cardiovascular death in current
smokers. We speculate that the profound effect of smoking
on cardiovascular mortality may follow a different mechanism
(acute plaque rupture) than other risk factors, including age,
Figure 2. Hazard ratios with 95% confidence intervals for an abnormal heart rate (HR) recovery predicting cardiovascular death stratified by
age, sex, presence of obesity, hypertension, diabetes mellitus, current smoking, use of HR-lowering drug, and level of cardiorespiratory fitness
(CRF). Poor CRF refers to functional aerobic capacity (FAC) <80%, reduced CRF to FAC 80% to 99%, and normal CRF to FAC ≥100% predicted. All
models are fully adjusted for age, sex, diabetes mellitus, hypertension, obesity, current smoking, and poor CRF. Hazard ratios for cardiovascular
death are compared by the Z-score method. Hazard ratio bars filled with striped pattern indicate nonsignificant findings.
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sex, obesity, hypertension, and poor CRF, but the limited
utility of HR recovery in current smokers may also reflect low
statistical power attributable to the relatively small number of
current smokers in the cohort (11%).
Another important clinical question about HR recovery
interpretation istheuseofHR-loweringdrugs,mainlyb-blockers.
Of the 1761 (8.9%) patients taking anyHR-lowering drug, almost
all (1667, 94.7%)were taking ab-blocker. Although therewas no
difference in HR recovery in patients taking or not taking HR-
lowering drug, an abnormal HR recovery did not significantly
predict cardiovascular death in patients taking an HR-lowering
drug. We explain this paradoxical finding by pointing out that an
abnormal HR recovery indicates reduced parasympathetic tone
with a resultant imbalance between sympathetic and parasym-
pathetic tone. Blocking sympathetic tone may restore that
balance and eliminate the hazard associated with the abnormal
HR recovery. However, as may also have been the case with
current smoking, the small number of patients in this primary
prevention cohort taking a b-blocker may have also limited our
ability to show significance in this group. Prior studies have
tested the role of b-blockers on HR recovery. One study found
significant impact of b-blocker use on HR recovery, but they
included patients with cardiovascular diseases.29 Karnik et al
stated that b-blocker use improves HR recovery in patients with
positive exercise stress echocardiography, does not affect HR
recovery in patients with negative exercise stress echocardio-
graphy, and can be used for mortality prediction,30 the latter
finding incontrast towhatwehaveobserved ina low-riskprimary
prevention cohort. Also in apparent contrast to our findings, the
study of Myers et al, which included 1910 male veterans,
suggested that b-blockade had minimal impact on the prognos-
tic power of HR recovery.31 The interaction ofb-blockers andHR
recovery may require further clarification.
Our study is also the first to stratify HR recovery according to
CRF. Better CRF is clearly associated with better HR recovery,
while the prognostic significance of an abnormal HR recovery is
inversely related to CRF. The limited utility of HR recovery in
patients with normal CRFmay be a consequence of the low rate
of cardiovascular mortality (109 deaths, 1.4%) in this subgroup.
The principle that “fitness trumps other risk factors” has
also been observed with respect to obesity and diabetes
mellitus,32,33 and also applies to ST-segment changes during
exercise.1,34 What is more important, perhaps, is the observa-
tion that abnormal HR recovery is a strong predictor of
cardiovascular death in patients with poor CRF, indicating that
abnormal HR recovery is more than just “deconditioning.”
Conclusion
This study confirmed the hypothesis that HR recovery has
prognostic significance in a primary prevention cohort. A unique
finding is that an abnormal HR recovery predicts not only total
mortality, as previously demonstrated, but is an even stronger
predictor of cardiovascular death and, surprisingly, also
predicts non-cardiovascular death. We demonstrate that
impaired HR recovery is associated with a number of well-
established cardiovascular risk factors, including diabetes
mellitus, hypertension, current smoking, and poor CRF, but is
not affected by patient sex or taking an HR-lowering drug. We
further show that HR recovery performs equally well in all adult
age groups and in both men and women and patients stratified
by obesity, hypertension, or diabetes mellitus. On the other
hand, HR recovery is less useful in patients with normal CRF, in
current smokers, or in those taking a b-blocker. We strongly
endorse previous recommendations that HR recovery should be
measured and reported on every exercise test.14
Strength and Limitations
The strengths of our study include a large consecutive cohort
with complete mortality follow-up over a long time period. We
have also divided mortality according to cardiovascular and
non-cardiovascular death. Exercise test data were robust and
complete, and important data on comorbidities and pharma-
cotherapies were available. Our study reflected the limited
racial diversity seen in Minnesota, so our results may not be
applicable to more diverse racial or ethnic groups. Overall
mortality was low, reflecting the status of Minnesota as a
state with low total and cardiovascular mortality. However, we
might speculate that exercise HR responses might be even
more important in a higher-risk population.
Exercise tests were conducted in a clinical environment, and
patients were instructed to exercise to subjective fatigue. Gas
exchange was not measured to confirm the level of metabolic
effort by respiratory exchange ratio.Weare usingCRFat a single
timepoint. The exercise testmay thus reflect recent, rather than
lifetime, physical activity patterns for some patients.
We identified HR recovery as the change during the first
minute of the active recovery period; we thus cannot comment
on the value of HR recovery as measured over different time
points, such as at 2, 3 or 5 minutes post exercise or where an
active recovery was not employed (as in stress echocardiogra-
phy).
For our nonimaging noncardiopulmonary stress tests, we
generally used the Bruce protocol, so we did not have a
sufficient number of patients of cycle ergometer or treadmill
tests on other protocols to perform similar analyses of HR
recovery.
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